Delivery Order SPE2DB20D1102-SPE2DB25FC6RL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,357.62 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, an ergot alkaloid medication used primarily in obstetric settings. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylergon 0.2mg in a 12-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,142.49 and has an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were utilized for this award,...
- This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order valued at $3,589.92 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, was awarded by the Defense Logistics Agency (DLA) and involves the delivery of METHYLERGONOVINE 0.2 MG/ML medication with an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The award has a completion date of February 5, 2024 and a potential value of $7,083.54. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp, as the prime contractor, has received numerous previous awards from DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a $1,144.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.2 mg/ml vials of methylergonovine under contract number 4561598047. Performance will take place in Conshohocken, Pennsylvania over one day from July 25 to July 26, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply this pharmaceutical product in support of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
- The Defense Logistics Agency Troop Support Medical awarded a $609.95 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for the supply of methylergonovine maleate. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA Troop Support Medical requirements. The contract has a period of performance from July 6, 2023 through August 29, 2023. Amerisourcebergen Drug Corp...
- This federal contract award, with a ceiling value of $1,397.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566801884 - METHYLERGONOVINE 0.2 MG TABLET 28S, with an ultimate completion date of December 30, 2024. The contract is not designated with a set-aside and appears to be an open competition award. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $1,682.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,206,972 units of Methylergonovine 0.2 mg tablets by October 28, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6RLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical commodity supporting military and federal healthcare operations. This award is issued as a child delivery order under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and prime vendor for federal medical procurement, AmerisourceBergen Drug Corp provides comprehensive pharmaceutical and medical supply support to military healthcare systems, the Defense Health Agency, and other government entities worldwide. The parent contract vehicle enables the contractor to fulfill varied medical commodity requirements across multiple therapeutic domains through flexible ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/25/25 |